Patent · US Expired

Method of treating reproductive system cancer by administering follistatin-3

US7208470B2 · kind B2 · utility

8Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2005
Grant dateApr 24, 2007
Priority date
Expiry dateJun 17, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/026
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel follistatin-3 protein which is a member of the family of inhibin-related proteins. In particular, isolated nucleic acid molecules are provided encoding the human follistatin-3 protein. Follistatin-3 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of follistatin-3 activity. Also provided are diagnostic methods for detecting reproductive system-related disorders and disorders of the regulation of cell growth and differentiation and therapeutic methods for treating reproductive system-related disorders and disorders of the regulation of cell growth and differentiation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.